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Abstract
Background: Gain-of function or dominant-negative mutations in the voltage-gated potassium channel KCNC3 (Kv3.3) were
recently identified as a cause of autosomal dominant spinocerebellar ataxia. Our objective was to describe the frequency of
mutations associated with KCNC3 in a large cohort of index patients with sporadic or familial ataxia presenting to three US
ataxia clinics at academic medical centers.
Methodology: DNA sequence analysis of the coding region of the KCNC3 gene was performed in 327 index cases with
ataxia. Analysis of channel function was performed by expression of DNA variants in Xenopus oocytes.
Principal Findings: Sequence analysis revealed two non-synonymous substitutions in exon 2 and five intronic changes,
which were not predicted to alter splicing. We identified another pedigree with the p.Arg423His mutation in the highly
conserved S4 domain of this channel. This family had an early-onset of disease and associated seizures in one
individual. The second coding change, p.Gly263Asp, subtly altered biophysical properties of the channel, but was
unlikely to be disease-associated as it occurred in an individual with an expansion of the CAG repeat in the CACNA1A
calcium channel.
Conclusions: Mutations in KCNC3 are a rare cause of spinocerebellar ataxia with a frequency of less than 1%. The
p.Arg423His mutation is recurrent in different populations and associated with early onset. In contrast to previous
p.Arg423His mutation carriers, we now observed seizures and mild mental retardation in one individual. This study confirms
the wide phenotypic spectrum in SCA13.
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Introduction
Dominant spinocerebellar ataxias (SCA) are heterogeneous
neurological diseases with phenotypes consisting of cerebellar
ataxia, extrapyramidal signs, dysarthria, oculomotor abnormali-
ties, motor neuron signs, cognitive decline, epilepsy, autonomic
dysfunction, sensory deficits, and psychiatric manifestations.
Currently, twenty-nine distinct SCA loci are known and mutations
identified for 17 of the SCAs.
The most common mutation observed is a DNA CAG repeat
expansion resulting in an enlarged poly-glutamine domain in the
respective protein. In addition to translated CAG-repeat mutations,
a number of non-CAG ataxia genes have been identified with
functions as diverse as protein kinases, cytoskeletal and mitochon-
drial proteins, and proteins regulating intracellular calcium stores
[1,2,3,4,5]. We previously described KCNC3 (Kv3.3, OMIM#
605259 RefSeq NG_008134.1, NP_004968.2 and NM_004977.2
in GenBank) as the gene mutated in SCA13 [6,7,8,9,10]. Affected
individuals ina Frenchpedigree withearly-onsetataxiasegregateda
p.Phe448Leu mutation. A p.Arg420His mutation segregated in a
Filipino pedigree with late onset and slow progression of ataxic
symptoms. In addition, two families of European descent with early
onset ataxia segregated a p.Arg423His mutation.
We now describe the analysis of a large number of ataxia
patients from mixed-ethnicity American pedigrees with autosomal
dominant or sporadic ataxia of early or late onset. We show that
the p.Arg423His mutation, originally described in Europeans, is
recurrent in this American cohort.
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Ethics Statement
All subjects gave written consent and all work was approved at
their respective institutions: Institutional Review Board at the
University of Minnesota; Institutional Review Board at the
University of Chicago and the University of Washington Human
Subjects Review Committee.
Identification of Index cases
The study group was composed of 327 index cases from
sporadic ataxia patients and from pedigrees with autosomal
dominant ataxia. Three 1
st degree relatives of index cases with
non-synonymous DNA changes were studied in addition. The
ethnic composition of these index cases was composed of 61.8%
Caucasian, 1.5% African American, 1.2% Hispanic and 35.5%
other. In 22.1% of index cases individuals came from pedigrees
with autosomal dominant inheritance, in 21.2% ataxia was
familial without a clear mendelian pattern. In 49.7% ataxia was
sporadic and in 7% of index cases family history was unknown.
Index cases had both late as well as early disease onset.
All patients presented to three ataxia subspecialty clinics in
academic medical centers and had undergone clinical examina-
tions and genetic tests to exclude ATNX1, ATXN2, ATXN3,
CACNA1A, ATNX7, and TBP (OMIM# 164400, 183090,
109150, 183086, 164500, 607136) CAG expansion mutations,
although not all gene tests were conducted in all patients.
The control group included 284 alleles contributed by 77
normal individuals living in France, 10 index individuals from
French families in the CEPH pedigree set and 55 US individuals
that represented spouses of patients with Parkinson disease that
were sequenced in a prior study [11]. DNA samples were collected
and stored using standard procedures.
Mutation screening and analysis of channel function was done
as described in Figueroa et al. 2010 [11] . Each fragment
containing mutations was amplified by PCR and sequenced a
second time to confirm that the identified mutations were not due
to PCR artifacts.
Electrophysiology
Mutations were made in a human wild-type Kv3.3 cDNA clone
(kind gift of Dr. James L. Rae) using the QuikChange kit
(Strategene) [12]. Mutations were verified by sequencing. Run off
transcripts were prepared using the mMessage mMachine kit
(Ambion). Wild type and mutant subunits were separately
expressed by injecting RNA into Xenopus oocytes. Channel activity
was recorded 2–3 days later using a two electrode voltage clamp
[13]. During electrophysiological experiments, oocytes were
bathed in a solution containing 4 mM KCl, 85 mM NaCl,
1.8 mM CaCl2, and 10 mM HEPES, pH 7.2. To measure tail
currents, the bath solution was switched to 89 mM RbCl, 2.4 mM
NaHCO3, 0.82 mM Ca(NO3)2, 0.41 mM CaCl2 and 10 mM
HEPES, pH 7.2. Electrode resistances ranged from 0.3 to
0.8 MV.
The voltage dependence of activation was determined from
normalized isochronal tail current amplitudes. Wild-type Kv3.3 or
p.Gly263Asp currents were evoked by stepping from 290 mV to
various test potentials, followed by repolarization to 290 mV.
Isochronal tail current amplitudes were normalized to the
maximal value obtained in the experiment and plotted versus test
potential. Data were fitted with single Boltzmann functions to
determine the midpoint of activation and slope factor, which are
provided as mean 6 SEM. These parameters did not differ
significantly between wild type and p.Gly263Asp channels
(Student’s t-test). To obtain values for the activation and
deactivation time constants, tact and tdeact, currents were fitted
with a single exponential function. Values are provided as mean 6
SEM. Statistical significance was evaluated using one-way
ANOVA (p,0.05).
Results
Genetics
Exons 1–4 of the KCNC3 gene were sequenced including exon-
intron boundaries for introns 1 and 2 as well as the entire small
intron 3. Table 1 summarizes DNA sequence changes found in
327 index cases and 142 controls. All variants were present in the
heterozygous state. Exon 5 was not analyzed as it does not contain
any coding sequences. We identified a total of 12 allelic variants.
These consisted of 11 single nucleotide changes, and one 1 bp
duplication. Four variants were located in the coding region. Of
these, two resulted in amino acid changes, one changing an
arginine to a histidine (p.Arg423His) and one changing a glycine
to aspartic acid (p.Gly263Asp). The two remaining coding variants
resulted in synonymous changes. Variant c.1257C.A was a 3
rd
base wobble at amino acid position Val 419 in two related
individuals, the other c.1404C.T was also a 3
rd base wobble
found at amino acid Tyr 468. Although these variants were only
found in cases, they likely represent very rare benign polymor-
phisms as they do not change the amino acid sequence or
introduce cryptic splice sites.
A number of variants that did not change the predicted amino
acid sequence were identified either in the 59-UTR or in intron 3;
none of the 59-UTR variants were found in the controls. Other
than exon-intron boundaries, we did not attempt to sequence
introns with the exception of intron 3 owing to its small size. Four
sequence variants were detected in this intron. One variant
occurred at a slightly higher frequency in cases versus controls,
g.13858G.A with an allele frequency 0.46% frequency in cases
and 0.35% in controls. This finding is similar to that reported in
our previous study, where g.13858G.A in intron 3 was relatively
common with an allele frequency of 3.65% in cases. When
combining cases from both studies, this variant has a combined
total allelic frequency of 0.62% in affected individuals versus
0.35% in controls.
Phenotypes of Patients with the p.Arg423His mutation
DNA electropherograms of the family found to carry the
p.Arg423His mutation are shown in Figure 1 and their clinical
phenotypes in Table 2. The index case (H2591) is a Caucasian
female who had onset of the disease in infancy with delayed
motor milestones and ataxic gait. At age 48, she presented at the
neurology clinic with dysarthria, ataxia, mild horizontal nystag-
mus, hyperactive tendon reflexes and a normal sensory exam.
The patient indicated that she had been clumsy all her life and
started walking at 14 months of age. She did not exhibit cognitive
impairment with an IQ in the normal range. MR Imaging
showed cerebellar midline and cortical atrophy (Fig. 2), EMG
and nerve conduction velocities were normal. This patient has
been followed for 10 years and has had very little change but
there has been some moderate deterioration in her gait. The son
(H2629) of the index case had normal initial milestones but was
also noted to be delayed throughout childhood with awkward fine
motor control and was unable to walk independently until 8 years
of age. He developed seizures in infancy, and imaging at age 3
showed a small cerebellum. On examination at age 17, he
presented with dysmetria, dysarthria, nystagmus, and hyperactive
tendon reflexes. Cognitive impairment was evident with an
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for publication.
The daughter (H2630) who did not carry the p.Arg423His
mutation was examined at age 15 and had no abnormal
neurological findings. The affected son and unaffected daughter
both carried a c.1257C.A variant, a 3
rd base wobble at amino
acid position Val 419 (Fig. 1). It remains possible that this variant
may worsen symptoms in carriers of the p.Arg423His mutation.
Functional Analysis
To characterize the effects of the novel mutation on channel
function, mutant p.Gly263Asp was introduced into wild type
human Kv3.3 [12]. Wild type and mutant subunits were
separately expressed in Xenopus oocytes and channel activity was
recorded with a two electrode voltage clamp [13].
The p.Gly263Asp subunit produced functional channels when
expressed alone (Fig. 3A). The voltage dependence of activation
was determined as a function of voltage and compared to wild type
(Fig. 3B). The data sets were fitted with single Boltzmann
functions, which yielded half activation voltages of 5.360.5 mV
and 2.760.8 mV and slope factors of 1060.3 and 10.360.7 for
wild-type and p.Gly263Asp channels, respectively (Fig. 3B). These
values did not differ significantly, indicating that the p.Gly263Asp
mutation had no detectable effect on the steady state properties of
activation. In contrast, the p.Gly263Asp mutation did alter
activation and deactivation kinetics. Evoked currents and tail
currents were fitted with single exponential functions to charac-
terize activation and deactivation kinetics, respectively (Fig. 3C,
3D). p.Gly263Asp channels activated more quickly and deactivat-
ed more slowly relative to wild type. At 0 mV, p.Gly263Asp
channels opened ,1.5-fold more rapidly than wild type channels
(Fig. 3C). At 270 mV, p.Gly263Asp channels closed ,1.5-fold
more slowly than wild type channels (Fig. 3D). Although relatively
modest in size, these changes in kinetics were statistically
significant.
As the functional changes were significant, but much less severe
than the p.Phe448Leu mutation previously observed in a French
pedigree, we pursued two additional lines of investigation to
determine whether p.Gly263Asp was a rare variant or disease-
causing. First, we examined the conservation of the changed
amino acid in other species and in other ion channels. The glycine
at position 263 is highly variable and not conserved even among
Kv3 family members. Second, we investigated whether this patient
had any other known mutations associated with a progressive
ataxia. Indeed, subsequent analysis revealed a DNA CAG repeat
expansion in the CACNA1a gene causing SCA6. The patient
carried a pathologic expansion with 23 CAG repeats with a typical
pure cerebellar phenotype with onset in midlife. Thus, the
KCNC3
Gly263Asp allele likely represents a rare benign polymor-
phism.
Discussion
We report findings from DNA sequence analysis of the human
KCNC3 gene in a large mixed ethnicity American cohort of
autosomal dominant early and late onset ataxia patients. Overall,
DNA variants located in exons and exon-intron boundaries were
rare. We identified twelve nucleotide changes in 13 sporadic, 5
familial and 2 cases with unknown family history.
Of these, only one variant can be considered disease-causing.
The arginine to histidine amino acid change at codon 423 has
been observed in two other pedigrees of European ancestry [11].
Similar to those patients, the two individuals carrying the
KCNC3
Arg423His allele had early-onset and slow progression.
One individual had mild mental retardation and seizures as well.
Seizures have been previously observed with the KCNC3
Arg420His
mutation, but not with the KCNC3
Arg423His allele. Mental
retardation had only been observed with the KCNC3
Phe448Leu
mutation [11]. Thus, this study confirms the wide phenotypic
spectrum associated with KCNC3 mutations.
The p.Arg423His mutation is located in the highly conserved S4
domain of the channel. The S4 domain is thought to act as the
main voltage sensing element [14,15] and is involved in channel
activation [16]. Both the p.Arg420His and p.Arg423His mutations
exhibited a strong dominant negative effect when expressed at a
1:1 ratio of wild type to mutant subunit, which is the expected
ratio found in SCA13 patients.
We identified another non-synonymous variant that was not
present in controls. This novel heterozygous variant c.788G.A,
p.Gly263Asp was found in one patient. Expression of this variant
Table 1. Sequence Variants Found in Index Cases.
Location Type Flanking Sequence Genomic Position Coding Position Amino Acid Change % Cases % Controls
59 UTR Non-coding CGTCTTT/GAAATAG g.4870T.G 0.60 0.00
59 UTR Non-coding AGCCAAT/ACGCTCC g.5065T.A c.-231T.A p.= 0.30 0.00
59 UTR Non-coding CTCCCC/CC/TAAGCC g.5186_5187dup c.-110_-109dup p.= 0.15 0.00
59 UTR Non-coding GCCCCCG/TCTACCT g.5203G.T c.-94G.T p.= 0.15 0.00
Exon 1 Coding CGGGCGG/ACGCGGG g.6083G.A c.788G.A p.Gly263Asp 0.15 0.00
Exon 2 Coding CTTCGTC/ACGCATC* g.10682C.A c.1257C.A p.= 0.30 0.00
Exon 2 Coding TTCTGCG/ACATCTT g.10693G.A c.1268G.A p.Arg423His 0.30 0.00
Exon 2 Coding TTACTAC/AGCTGAG g.10829C.A c.1404C.A p.= 0.30 0.00
Intron 3 Non-coding GCCCCCC/ACTACTG g.13799C.A c.2170+14C.A 0.76 0.70
Intron 3 Non-coding AGAGGGG/AGATGGG g.13858G.A c.2170+73G.A 0.46 0.35
Intron 3 Non-coding CCCAACT/CCTCTGG** g.14003T.C c.2171-26T.C 0.15 0.35
Intron 3 Non-coding GGGGGAG/AGAGGCG g.13868G/A c.2170+83G.A 0.15 0.00
RefSeq NG_008134.1, NM_004977.2, NP_004968.2, % reflects allele frequency.
*Variant Found in patient with p.Arg423His and sister.
**Known SNP rs35578310.
doi:10.1371/journal.pone.0017811.t001
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tions kinetics, but the changes were relatively mild compared with
the previously reported KCNC3
Phe448Leu mutation that displayed
a much more significant gain-of-function in our heterologous
expression system [6]. In addition, the glycine at position 263 is
conserved in only 44 out of the 164 of the voltage-gated K channel
family. Further genetic analysis revealed that the patient carried a
repeat-expansion mutation in the CACNA1a gene. His brother,
also affected with SCA6, was not found to have the KCNC3
amino acid change. Thus, it is unlikely that the subtle changes in
channel function seen in vitro, are responsible for ataxia in vivo.
As sequencing of the KCNC3 gene is available in academic and
commercial laboratories, it is likely that additional rare DNA
variants will be identified. Great caution will need to be exercised
in the interpretation of these variants. As the KCNC3
Gly263Asp
variant shows, even the presence of subtly changed channel
function in heterologous cell systems does not prove that a DNA
variant is causative in vivo. And unless very large numbers of
control alleles are examined, it will be difficult to distinguish
between disease-associated variants and very rare polymorphisms
on purely genetic grounds.
Problems in interpreting our KCNC3
Gly263Asp variant are
reminiscent of similar issues in a variant of the SCNA (Nav1.4)
sodium channel subunit. Although a SCNA
Ser906Thr variant
segregated perfectly with periodic paralysis in several large
pedigrees and was shown to alter entry into and recovery from
slow channel inactivation, it was later identified in up to 5% of the
normal population without apparent association with disease [17].
Our present data support the notion that SCA13 is a rare ataxia
and that KCNC3 mutations causing SCA13 have arisen in a
number of ethnic groups. Despite the enormous progress that has
been made in the understanding of the genetic basis of hereditary
Figure 1. DNA electropherograms of a family with the p.Arg423His mutation. H2591shows the p.Arg423His mutation (arrow, top), her son
(H2629) shows the p.Arg423His mutation and the c.1257C.A variant, and her daughter (H2630) shows the c.1257C.A change, but lacks the
mutation.
doi:10.1371/journal.pone.0017811.g001
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study, about half of the cohort had sporadic ataxia. Although 62%
of the DNA changes were found in these patients, none were
disease- causing and found in non-coding regions. A number of
previous studies have also looked for gene mutations in sporadic
ataxias and the frequency of positive genetic tests in apparently
sporadic ataxia patients ranged from 2% to 22% [18,19,20,21].
The discrepancies between studies are probably due to variable
Table 2. Clinical and mutation findings of p.Arg423His index patient and relatives.
ID
Index
Patient
Age at
Onset
Age at
Exam
Sign at
Onset
Cerebellar
Signs
Neurologic
Examination IQ Imaging Progression
Coding
Position
Amino acid
Change
H2591 Yes Infancy 48 Ataxic gait Yes Dysarthria,
mild horizontal
nystagmus,
hyperactive
tendon reflexes.
Normal sensory
exam.
IQ in
normal
range
Cerebellar
Atrophy,
EMG/NCV
normal
Clumsy all her
life walked at
age 14 months.
c.1268G.A p.Arg423His
H2629 No, son of
index
Infancy 17 Ataxic gait
and seizures
Yes Dysmetria,
dysarthria,
nystagmus,
hyperactive
tendon reflexes.
IQ
estimated
at 65
Small
cerebellum
at age 3
All milestones
were delayed.
Unable to walk
independently
until 8 years of
age.
c.1268G.A p.Arg423His
H2630 No,
daughter
of index
NA 15 Normal Not done
Nucleotide numbering for cDNA –based nomenclature uses 1+ as to the A of the ATG translation initiation codon in Genebank RefSeq NM_004977.2.
The initiation codon is codon 1. RefSeq NG_008134.1, NP_004968.2.
doi:10.1371/journal.pone.0017811.t002
Figure 2. MRI of Patient with the p.Arg423His mutation. Cerebellar atrophy in a 48 year old female (H2591) with ataxia and the KCNC3
Arg423His
mutation. Midsagittal T1-weighted MRI of the brain shows a small atrophic cerebellum with a normal appearing brainstem.
doi:10.1371/journal.pone.0017811.g002
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population.
Two of the mutations involving arginines in the S4 voltage
sensor domain are recurrent in different populations with overall
similar phenotypes for the specific mutation. The p.Phe448Leu
mutation, although non-recurrent at this point, segregated in a
large pedigree and resulted in significantly altered biophysical
properties of the KCNC3 channel. As demonstrated by the
KCNC3
Gly263Asp variant, great care needs to be exercised when
interpreting other rare coding changes even when they show subtle
changes in a heterologous expression system.
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